SCHEMBL7144577

SCHEMBL7144577

Cc1cc(C)c(O)c([C@H](Nc2ccc(C#N)cc2)C(=O)NCc2ccccc2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A3 P43003 1/20 0.44
SLC1A2 P43004 1/20 0.44
F7 P08709 5/20 0.41
F2 P00734 4/20 0.41
PRSS1 P07477 4/20 0.41
F10 P00742 3/20 0.41
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
ALDH1A1 P00352 3/20 0.40
LMNA P02545 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
SCN5A Q14524 1/20 0.39
SCN9A Q15858 1/20 0.39
F3 P13726 1/20 0.38
MMP2 P08253 2/20 0.38
MMP3 P08254 1/20 0.38
KDM4E B2RXH2 1/20 0.37
GLA P06280 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7144574 1.00 SLC1A3 (0.44) SLC1A3SLC1A2F7F2PRSS1
SCHEMBL8120592 0.85 F7 (0.42) SLC1A3SLC1A2F7F2PRSS1
SCHEMBL5882342 0.83 MMP2 (0.43) MEN1KMT2AALDH1A1LMNAGAA
SCHEMBL7142631 0.79 F2 (0.49) SLC1A3SLC1A2F7F2PRSS1
SCHEMBL7142637 0.79 F2 (0.49) SLC1A3SLC1A2F7F2PRSS1
SCHEMBL7144966 0.78 ADRB3 (0.43) SLC1A3SLC1A2F7F2PRSS1
SCHEMBL7144961 0.78 ADRB3 (0.43) SLC1A3SLC1A2F7F2PRSS1
SCHEMBL7147512 0.77 F2 (0.49) SLC1A3SLC1A2F7F2PRSS1
SCHEMBL7147502 0.77 F2 (0.49) SLC1A3SLC1A2F7F2PRSS1
SCHEMBL7146106 0.77 F7 (0.51) SLC1A3SLC1A2F7F2PRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0921116-B1 N-(4-carbamimido-phenyl)-glycine amide derivatives HOFFMANN LA ROCHE (CH) 2003-06-18 EP disclosed
US-6140353-A USED AS MEDICAMENTS FOR THE TREATMENT AND/OR PREVENTION OF THROMBOSES, APOPLEXY, CARDIAC INFARCTION, INFLAMMATION AND ARTERIOSCLEROSIS OR AS ANTITUMOR AGENTS HOFFMANN-LA ROCHE INC. (US) 2000-10-31 US disclosed
EP-0921116-A1 N-(4-carbamimido-phenyl)-glycine amide derivatives F. HOFFMANN-LA ROCHE AG (CH) 1999-06-09 EP disclosed